Effect of selenium versus placebo on clinical symptoms after coronary artery bypass graft in patients with coronary artery stenosis

Effect of selenium versus placebo on clinical symptoms after coronary artery bypass graft in patients with coronary artery stenosis: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N223

Enrollment

60

Registered

2018-06-14

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery stenosis. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group: Intravenous injection of selenium 100 mic gr single dose 10 min before detaching the pump. Intervention 2: Control group: Intravenous injection of distilled water 2

Sponsors

Hamedan University of Medical Sciences

Lead Sponsor

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 75 years Coronary artery stenosis Indication of coronary artery bypass graft

Exclusion criteria

Exclusion criteria: Emergency patients A history of heart surgery Valvular disease

Design outcomes

Primary

Measure	Time frame
Assessing dysrhythmia. Timepoint: Every 6 hours for 24 hours. Method of measurement: Using a monitor.	—

Secondary

Measure	Time frame
Assessing inotrope usage. Timepoint: 24 hours after surgery. Method of measurement: With checking patient's medical record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Monazami Tabar

Hamedan University of Medical Sciences

afarhanchi1970@yahoo.com+98 81 3838 1740

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026